Isoprenoid Metabolism as a Therapeutic Target in Gram-Negative Pathogens

E-ISSN： 1873-4294|10|18|1858-1871

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.18, 2010-12, pp. : 1858-1871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Type III secretion system of Gram-negative bacteria: a potential therapeutic target?

By Müller Simone Feldman Mario F Cornelis Guy R

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 327-339

Informa Healthcare

Access to resources Recommend Favorite

&bgr;-lactam Resistance in Gram-negative Pathogens Isolated from Animals

Current Pharmaceutical Design, Vol. 19, Iss. 2, 2013-01 ,pp. : 239-249

Bentham Science Publishers

Access to resources Recommend Favorite

Detection of Gram-Negative &bgr;-Lactamase Producing Pathogens in the Clinical Lab

Current Pharmaceutical Design, Vol. 19, Iss. 2, 2013-01 ,pp. : 250-256

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topics: Resistance in Gram-negative Pathogens: A Threat to Global Health)

Current Pharmaceutical Design, Vol. 19, Iss. 2, 2013-01 ,pp. : 163-163

Bentham Science Publishers

Access to resources Recommend Favorite

Lipopolysaccharide as a Target for the Development of Novel Therapeutics in Gram-Negative Bacteria

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 91-106

Bentham Science Publishers

Access to resources Recommend Favorite